Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
ImmuPharma plc (IMM:LON) | 7.5 0 9.6% | Mkt Cap: 37.8m
Vadim Alexandre
4 pages
ImmuPharma (IMM.L) – CORP*: Appointment of Northland
Companies: ImmuPharma plc
Companies: XARZYTMEGPVCTIQEWMHIMMSFRCVSGPURPBURENTPTEC
Companies: TRLS SNX MWE SAAS SAA KRPZ IMM FAB DSW 8ZF
